KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Clover Health Investments (CLOV) EBIT (2019 - 2025)

Clover Health Investments' EBIT history spans 7 years, with the latest figure at -$49.3 million for Q4 2025.

  • For Q4 2025, EBIT fell 129.95% year-over-year to -$49.3 million; the TTM value through Dec 2025 reached -$85.5 million, down 86.95%, while the annual FY2025 figure was -$85.5 million, 86.95% down from the prior year.
  • EBIT reached -$49.3 million in Q4 2025 per CLOV's latest filing, down from -$24.4 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $7.2 million in Q2 2024 to a low of -$186.8 million in Q4 2021.
  • Average EBIT over 5 years is -$63.0 million, with a median of -$41.5 million recorded in 2023.
  • Peak YoY movement for EBIT: plummeted 884.9% in 2021, then soared 124.88% in 2024.
  • A 5-year view of EBIT shows it stood at -$186.8 million in 2021, then soared by 88.03% to -$22.4 million in 2022, then plummeted by 182.35% to -$63.1 million in 2023, then surged by 66.03% to -$21.4 million in 2024, then crashed by 129.95% to -$49.3 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's EBIT are -$49.3 million (Q4 2025), -$24.4 million (Q3 2025), and -$10.6 million (Q2 2025).